Books > Medicine > Clinical & internal medicine > Musculoskeletal medicine
|
Buy Now
Management of Medication-related Osteonecrosis of the Jaw, An Issue of Oral and Maxillofacial Clinics of North America, Volume 27-4 (Hardcover)
Loot Price: R1,657
Discovery Miles 16 570
|
|
Management of Medication-related Osteonecrosis of the Jaw, An Issue of Oral and Maxillofacial Clinics of North America, Volume 27-4 (Hardcover)
Series: The Clinics: Surgery
Expected to ship within 12 - 17 working days
|
Editor Salvatore Ruggiero, DMD, MD and authors review the
Diagnosis, Management and Prevention of Medication-related
Osteonecrosis of the Jaw. Articles will include: Osteoporosis and
bone modulation therapies: indications and outcomes; Antiresorptive
therapies for the treatment of malignant osteolytic bone disease;
Clinical presentation and staging of antiresorptive agent-induced
osteonecrosis of the jaw; Epidemiology and risk factors of
antiresorptive agent-induced osteonecrosis of the jaw; Basic
science research of antiresorptive agent-induced osteonecrosis of
the jaw: an update; Pathophysiology of antiresorptive agent-induced
osteonecrosis of the jaw: what we know and what we don't know; The
genetics of osteonecrosis of the jaw; Preventive strategies for
patients at risk of antiresorptive agent-induced osteonecrosis of
the jaw; Non-operative and operative therapies for treatment of
antiresorptive agent-induced osteonecrosis of the jaw; The role of
anti-angiogenic therapy in the development of osteonecrosis of the
jaw; Antiresorptive therapies: what they are and how do they work,
and more!
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
You might also like..
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.